大鸡巴操,操碰97,啪啪啪视频在线观看,免费人成网站www 549tv,www.天天综合,成人做爰黄AA片啪啪声无限下载,欧美精品乱伦,操人人操

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>

產(chǎn)品基本信息

產(chǎn)品編號：P141015

產(chǎn)品名稱：Paliperidone Laurate

產(chǎn)品CAS：

規(guī)格含量：25mg

產(chǎn)品價格：面議

聯(lián)系我們:

產(chǎn)品詳細介紹

標準品編號:	P141015
名稱:	Paliperidone Laurate
別名:	3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl Dodecanoate;
分子式:	C??H??FN?O?
外觀:	白色至淡黃色固體
熔點:	>105°C (dec.)
分子量:	608.79
儲存:	-20°C Freezer, Under inert atmosphere
溶解度:	Chloroform (Slightly), Dichloromethane (Slightly)
類別:	Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用:	Paliperidone Laurate is related to Paliperidone (P141000), which is a combined serotonin (5-HT2) and dopamine (D2) receptor antagonist. Also related to Paliperidone Palmitate (P141020) that is long-acting injectable atypical antipsychotic, used in the treatment of schizophrenia.
參考文獻	Tiberghien, F., et al.: Anticancer Drugs, 7, 568 (1996); Kansy, M., et al.: J. Med. Chem., 41, 1007 (1998); Kerns, E., et al.: J. Pharm. Sci., 90, 1838 (2001); Kerr, K., et al.: J. Biol. Chem., 276, 8657 (2001); Doran, A., et al.: Drug Metab. Dispos., 33, 165 (2005); Hough, D. et al.: Prog. Neuro-psychophamacol. Biol. Psych., 33, 1022 (2009); Samtani, M.N. et al.: Clin. Pharmacokin., 48, 585 (2009); Nasrallah, H.A. et al.: Neuropsychopharmacology, 35, 2072 (2010);

聯(lián)系我們

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>